NCS Testing Technology Co., Ltd.

SZSE:300797.SZ

12.66 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q1
Revenue 250.659202.751323.278233.059213.906176.961292.239193.266184.47145.445221.734201.26174.866103.776239.476140.743136.98668.251169.679140.777125.407110.562176.4136.38396.39996.399
Cost of Revenue 140.986116.401197.348110.085110.858101.003151.263111.24994.74479.408132.578107.56688.08154.068126.03780.07475.84850.257102.51778.00571.54760.80592.96981.04457.26457.264
Gross Profit 109.67386.35125.93122.974103.04875.958140.97682.01789.72566.03789.15693.69486.78649.708113.43960.66961.13817.99467.16162.77253.8649.75683.43155.33939.13539.135
Gross Profit Ratio 0.4380.4260.390.5280.4820.4290.4820.4240.4860.4540.4020.4660.4960.4790.4740.4310.4460.2640.3960.4460.4290.450.4730.4060.4060.406
Reseach & Development Expenses 26.05827.85429.50322.2320.70820.92157.12817.24713.81113.1520.55213.94214.16310.65516.929.7019.6418.13415.70611.1311.0477.92518.67930.65500
General & Administrative Expenses -10.63432.993-46.3579.632-16.34532.271-20.40853.441-6.616.936-30.12952.19-6.42116.8-17.7817.131-6.81512.668-19.55415.01-4.06211.457-16.805-5.4718.80418.804
Selling & Marketing Expenses 31.30431.07734.38232.62430.38126.10130.68828.21723.03620.58728.32525.11722.47620.89423.86919.70516.90513.80321.55516.73815.91816.95123.82814.2513.92113.921
SG&A 57.11662.87468.152112.25614.03658.37210.28181.65716.43637.523-1.80577.30716.05537.6946.08936.83610.08926.4712.00131.74811.85628.4097.0238.7833.38333.383
Other Expenses -0.070.179-2.966-0.093-0.2790.0440.323-0.211-1.120.457-0.1650.281.9141.057-3.580.4211.9196.4174.7451.4640.3340.6570.9640.76900
Operating Expenses 83.24490.549100.62284.41471.86973.989124.19865.87349.23246.34367.69158.44352.17643.22664.52137.95932.93829.06253.02238.74535.99234.47550.56335.66429.89429.894
Operating Income 26.429-4.19925.30835.11730.0821.66511.64429.98236.87517.1869.94536.26935.1046.44542.39622.80227.072-10.7214.48124.10217.32914.93732.26519.3028.4718.471
Operating Income Ratio 0.105-0.0210.0780.1510.1410.0090.040.1550.20.1180.0450.180.2010.0620.1770.1620.198-0.1570.0850.1710.1380.1350.1830.1420.0880.088
Total Other Income Expenses Net 8.746.19512.256-0.093-0.2790.0440.323-0.211-1.120.457-0.1650.281.9141.057-3.580.4211.9196.4174.7451.4640.3340.6570.9640.7690.8460.846
Income Before Tax 35.1691.99637.56435.02429.8031.70911.96729.77235.75517.6439.77936.54937.0197.50238.81623.22428.991-4.30319.22625.56617.66315.59433.22920.0719.3179.317
Income Before Tax Ratio 0.140.010.1160.150.1390.010.0410.1540.1940.1210.0440.1820.2120.0720.1620.1650.212-0.0630.1130.1820.1410.1410.1880.1470.0970.097
Income Tax Expense 4.901-2.977-0.8871.6174.276-1.825-9.4024.2513.7162.765-4.2035.5384.4720.8713.5753.2093.618-0.8241.8673.2952.1591.6293.992.0560.820.82
Net Income 36.11612.06643.88538.72933.2369.84739.58627.3432.03914.87813.99831.01532.5296.65135.29220.02925.372-3.47317.35322.27515.53113.97629.15318.068.5078.507
Net Income Ratio 0.1440.060.1360.1660.1550.0560.1350.1410.1740.1020.0630.1540.1860.0640.1470.1420.185-0.0510.1020.1580.1240.1260.1650.1320.0880.088
EPS 0.0970.0320.120.10.0890.0270.110.0730.0860.040.0380.0830.0870.0180.0950.0540.068-0.0090.0510.080.0560.050.10.0670.030.03
EPS Diluted 0.0970.0320.120.10.0890.0270.110.0730.0860.040.0380.0830.0870.0180.0950.0540.068-0.0090.0510.080.0560.050.10.0670.030.03
EBITDA 50.6721.93647.70738.28132.2152.76318.03515.71239.35420.38826.11634.65633.7716.52853.91322.46429.566-11.03513.80624.01318.66515.47633.13320.14511.74811.748
EBITDA Ratio 0.2020.010.1480.1640.1510.0160.0620.0810.2130.140.1180.1720.1930.0630.2250.160.216-0.1620.0810.1710.1490.140.1880.1480.1220.122